ICON's Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report
The report, based on extensive feedback from 159 industry professionals, underscored ICON's dominance across a wide range of performance metrics and highlights the company's unwavering commitment to innovation, operational excellence, and customer satisfaction.
Key highlights from the report include:
Sponsor satisfaction: For phase 1 research, ICON outperformed all other large CROs claiming the highest overall sponsor satisfaction score of 7.4 on a scale of 1-10.
Outstanding operational metrics: ICON outperformed the average performance score of other large CROs in all 17 operational metrics, with a considerable lead differential in 14. These metrics are grouped into three categories of critical service capabilities including delivery metrics (such as adhering to project timelines), staff characteristics (like therapeutic expertise), and accessibility metrics (clinic availability, for example).
Robust brand strength: Across the four brand strength performance metrics of familiarity, leadership, reported recent use, and preference, ICON was the only large CRO to improve its scores across the board compared to ISR's 2024 iteration of this research, with the largest gains in leadership and preference.
Consistency of excellence: For six consecutive years, ICON has outperformed the weighted average performance scores of the other large CROs in phase 1 clinical trials, demonstrating sustained excellence and reliability.
"ICON's strong results in this report reflect the dedication, expertise, and innovation that drive our teams globally," said Steve Cutler, CEO. "Our consistent leadership in phase 1 clinical trials is a testament to our ability to meet and exceed client expectations, deliver high-quality outcomes, and advance breakthroughs in early-phase development."
The benchmarking report used a rigorous methodology to ensure results reflected ICON's true impact and performance in the competitive phase 1 landscape. ISR screened participants to ensure relevance of role and responsibility, and mandated a recent interaction with a CRO. The survey data was collected in Q4 2024.
For more information, please visit www.iconplc.com/earlyclinical
About ICON plc
ICON plc is a world-leading clinical research organisation powered by healthcare intelligence. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 41,250 employees in 97 locations in 55 countries as at March 31, 2025. For further information about ICON, visit: www.iconplc.com.
About ISR Market Research:
ISR utilises primary research methodologies to offer novel insights into the drug development industry. As an independent market research partner focusing on the life sciences space, ISR helps clients make data-informed decisions with specificity and precision that generalist firms can't match. ISR's analysts are industry experts in their own right with over 15 years of experience in this niche. They also diligently curate membership for ISR's Life Science Panel of respondents. Panel members are from a wide spectrum of geographies and job levels across a variety of roles & responsibilities, and their valuable experiential data informs both ISR's off-the-shelf syndicated reports and robust custom research capabilities.
https://isrreports.com/
https://www.linkedin.com/company/isrreports
ICON/ICLR-G
View source version on businesswire.com: https://www.businesswire.com/news/home/20250716572617/en/
Contacts
Media contacts: Lisa Henry (GMT time zone)Weber Shandwick (PR adviser)+447785 458203lhenry@webershandwick.com
ICON Press Officeiconnews@webershandwick.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
LGI Homes, Inc. Reports July 2025 Home Closings
THE WOODLANDS, Texas, Aug. 05, 2025 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) today announced it closed 381 homes in July 2025. As of July 31, 2025, the Company had 143 active selling communities. About LGI Homes, Inc. Headquartered in The Woodlands, Texas, LGI Homes, Inc. is a pioneer in the homebuilding industry, successfully applying an innovative and systematic approach to the design, construction and sale of homes across 36 markets in 21 states. As one of America's fastest growing companies, LGI Homes has closed over 75,000 homes since its founding in 2003 and has delivered profitable financial results every year. Nationally recognized for its quality construction and exceptional customer service, LGI Homes was named to Newsweek's list of the World's Most Trustworthy Companies. LGI Homes' commitment to excellence extends to its more than 1,000 employees, earning the Company numerous workplace awards at the local, state, and national level, including the Top Workplaces USA 2025 Award. For more information about LGI Homes and its unique operating model focused on making the dream of homeownership a reality for families across the nation, please visit the Company's website at CONTACT:Joshua D. FattorExecutive Vice President, Investor Relations and Capital Markets(281) 210-2586investorrelations@ in to access your portfolio
Yahoo
15 minutes ago
- Yahoo
Lucid (NASDAQ:LCID) Posts Q2 Sales In Line With Estimates But Stock Drops
Luxury electric car manufacturer Lucid (NASDAQ:LCID) met Wall Street's revenue expectations in Q2 CY2025, with sales up 29.3% year on year to $259.4 million. Its non-GAAP loss of $0.24 per share was 11.1% below analysts' consensus estimates. Is now the time to buy Lucid? Find out in our full research report. Lucid (LCID) Q2 CY2025 Highlights: Revenue: $259.4 million vs analyst estimates of $259.1 million (29.3% year-on-year growth, in line) Adjusted EPS: -$0.24 vs analyst expectations of -$0.22 (11.1% miss) Adjusted EBITDA: -$632.1 million vs analyst estimates of -$624.3 million (-244% margin, 1.2% miss) Operating Margin: -310%, up from -393% in the same quarter last year Free Cash Flow was -$1.01 billion compared to -$741.3 million in the same quarter last year Sales Volumes rose 38.2% year on year (70.5% in the same quarter last year) Market Capitalization: $7.40 billion "We had our sixth consecutive quarter of record deliveries in Q2 and expect to continue this trend as we ramp up Lucid Gravity production in the second half of the year," said Marc Winterhoff, Interim CEO at Lucid. Company Overview Founded by a former Tesla Vice President, Lucid Group (NASDAQ:LCID) designs, manufactures, and sells luxury electric vehicles with long-range capabilities. Revenue Growth A company's long-term sales performance is one signal of its overall quality. Any business can experience short-term success, but top-performing ones enjoy sustained growth for years. Luckily, Lucid's sales grew at an incredible 280% compounded annual growth rate over the last four years. Its growth beat the average industrials company and shows its offerings resonate with customers. Long-term growth is the most important, but within industrials, a stretched historical view may miss new industry trends or demand cycles. Lucid's annualized revenue growth of 11% over the last two years is below its four-year trend, but we still think the results suggest healthy demand. We can dig further into the company's revenue dynamics by analyzing its number of units sold, which reached 3,309 in the latest quarter. Over the last two years, Lucid's units sold grew by 41.5% annually. Because this number is better than its revenue growth, we can see the company's average selling price decreased. This quarter, Lucid's year-on-year revenue growth of 29.3% was excellent, and its $259.4 million of revenue was in line with Wall Street's estimates. Looking ahead, sell-side analysts expect revenue to grow 121% over the next 12 months, an improvement versus the last two years. This projection is eye-popping and suggests its newer products and services will spur better top-line performance. Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link. Operating Margin Lucid's high expenses have contributed to an average operating margin of negative 477% over the last five years. Unprofitable industrials companies require extra attention because they could get caught swimming naked when the tide goes out. It's hard to trust that the business can endure a full cycle. On the plus side, Lucid's operating margin rose over the last five years, as its sales growth gave it operating leverage. Still, it will take much more for the company to reach long-term profitability. This quarter, Lucid generated a negative 310% operating margin. Earnings Per Share Revenue trends explain a company's historical growth, but the change in earnings per share (EPS) points to the profitability of that growth – for example, a company could inflate its sales through excessive spending on advertising and promotions. Although Lucid's full-year earnings are still negative, it reduced its losses and improved its EPS by 24.2% annually over the last two years. In Q2, Lucid reported adjusted EPS at negative $0.24, up from negative $0.31 in the same quarter last year. Despite growing year on year, this print missed analysts' estimates. We also like to analyze expected EPS growth based on Wall Street analysts' consensus projections, but there is insufficient data. Key Takeaways from Lucid's Q2 Results We struggled to find many positives in these results. Its EPS missed and its sales volume fell short of Wall Street's estimates. Overall, this was a softer quarter. The stock traded down 8.4% to $2.23 immediately following the results. Lucid may have had a tough quarter, but does that actually create an opportunity to invest right now? What happened in the latest quarter matters, but not as much as longer-term business quality and valuation, when deciding whether to invest in this stock. We cover that in our actionable full research report which you can read here, it's free. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
44 minutes ago
- Yahoo
Galaxy Digital stock sinks 5% after shocking earnings
Galaxy Digital stock sinks 5% after shocking earnings originally appeared on TheStreet. Galaxy Digital (Nasdaq: GLXY), a global crypto-focused financial services firm, reported financial results for the second quarter of 2025 on Aug. 5. The company generated a revenue of $8.66 million in Q2, down 2.5% year-over-year (YoY). Its adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) stood at $211 million, owing to a rise in virtual assets and other investments on its balance sheet. Galaxy also increased its Bitcoin holdings to 17,102 coins, worth $1.94 billion at the time of writing, adding 4,272 BTC during Q2. It also held $325 million in Ethereum, $180 million in SOL, and $45.8 million in XRP, among other crypto assets on its balance sheet. The company held crypto assets worth $3.56 billion in carrying value. However, Galaxy's earnings per share (EPS) during the quarter missed estimates, coming in at $0.08 as compared to the estimated $0.10. Founded by Mike Novogratz, the crypto-focused company went public on May its public debut, the GLXY stock has risen more than 16% in value. However, it fell more than 5% in a day to trade at $27.36 following the earnings miss. Most leading crypto stocks also reflected a dip in their value on the day. MicroStrategy (Nasdaq: MSTR), the world's leading Bitcoin treasury company, also fell 3.82% to $374.36. Coinbase Global (Nasdaq: COIN), the largest U.S. crypto exchange, dipped nearly 5.49% to $300.69. Robinhood Markets (Nasdaq: HOOD), the trading exchange offering cryptocurrencies and tokenized stocks, fell 2.14% to $104.10. Circle (NYSE: CRCL), the stablecoin company, also fell 4.50% to $157.40. HIVE Digital (Nasdaq: HIVE), the Bitcoin mining firm, fell 0.73% to $2.06. Galaxy Digital stock sinks 5% after shocking earnings first appeared on TheStreet on Aug 5, 2025 This story was originally reported by TheStreet on Aug 5, 2025, where it first appeared. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
